These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25003350)

  • 1. Novel treatments in acute lymphocytic leukemia.
    Stein AS
    Clin Adv Hematol Oncol; 2014 Apr; 12(4):212-4. PubMed ID: 25003350
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Shi HX; Han W; Zhan XH; Wang Y; Zhao T; Huang XJ
    Chin Med J (Engl); 2011 Jan; 124(2):246-52. PubMed ID: 21362375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic stem cell transplantation for patients with Philadelphia positive leukemia resistant to imatinib].
    Han W; Liu KY; Xu LP; Chen H; Liu DH; Chen YH; Zhang XH; Zhang YC; Chen Y; Wang Y; Wang J; Lu DP; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1974-7. PubMed ID: 19062738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia.
    Mann G; Gadner H
    Wien Klin Wochenschr; 2002 Feb; 114(4):141-2. PubMed ID: 12060979
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.
    Oliansky DM; Larson RA; Weisdorf D; Dillon H; Ratko TA; Wall D; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):16-7. PubMed ID: 21963620
    [No Abstract]   [Full Text] [Related]  

  • 6. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
    Hamidieh A; Kargar M; Jahani M; Alimoghaddam K; Bahar B; Mousavi SA; Iravani M; Jalali A; Jalili M; Ghavamzadeh A
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of allogeneic haematopoietic stem cell transplantation in the outcome of Ph+ acute lymphoblastic leukaemia treated with an imatinib-containing regimen.
    Costa LJ
    Br J Haematol; 2009 Sep; 146(5):576-7. PubMed ID: 19555375
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantation.
    Helton KJ; Patay Z; Triplett BM
    Bone Marrow Transplant; 2013 May; 48(5):729-31. PubMed ID: 23085831
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the understanding and treatment of pediatric leukemias.
    Maloney KW; Giller R; Hunger SP
    Adv Pediatr; 2012; 59(1):329-58. PubMed ID: 22789585
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia.
    Corker E; Astwood E; Williams J; Vora A
    Br J Haematol; 2012 Oct; 159(1):104-6. PubMed ID: 22804487
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim DW; Cho BS; Yoon JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Chung NG; Kim HJ; Min CK; Lee JW; Min WS; Park CW
    Leukemia; 2012 Nov; 26(11):2367-74. PubMed ID: 22705993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.
    Xue SL; Cui HX; Zou JY; Xue MX; Tang XW; Zhang YM; Wu DP
    Hematol Oncol; 2013 Dec; 31(4):206-12. PubMed ID: 23616245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies.
    Aljurf M; Zaidi SZ
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):739-54. PubMed ID: 16182175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic cell transplantation for high-risk ALL.
    Linker C; Damon L; Martin T; Blume K; Forman S; Snyder D; Wolf J; Negrin R
    Bone Marrow Transplant; 2011 Mar; 46(3):460-1. PubMed ID: 20531287
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
    Eckert C; Henze G; Seeger K; Hagedorn N; Mann G; Panzer-Grümayer R; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Schrauder A; Escherich G; Sramkova L; Niggli F; Hitzler J; von Stackelberg A
    J Clin Oncol; 2013 Jul; 31(21):2736-42. PubMed ID: 23775972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The allograft in acute lymphoblastic leukemia].
    Torlontano G; Di Girolamo G; Di Bartolomeo P; Angrilli F; Dragani A; Fioritoni G; Iacone A; D'Antonio D; Pomarici S; Amoroso A
    Haematologica; 1989 Oct; 74(5 Suppl):433-42. PubMed ID: 2512227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.